Your browser doesn't support javascript.
loading
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity.
Mankelow, Tosti J; Blair, Allison; Arnold, David T; Hamilton, Fergus W; Gillespie, Kathleen M; Anstee, David J; Toye, Ashley M.
Affiliation
  • Mankelow TJ; Bristol Institute for Transfusion Sciences, NHSBT, Bristol, UK.
  • Blair A; NIHR Blood and Transplant Research Unit in Red Cell Products, University of Bristol, Bristol, UK.
  • Arnold DT; Bristol Institute for Transfusion Sciences, NHSBT, Bristol, UK.
  • Hamilton FW; NIHR Blood and Transplant Research Unit in Red Cell Products, University of Bristol, Bristol, UK.
  • Gillespie KM; Infection Sciences, Southmead Hospital North Bristol NHS Trust, Bristol, UK.
  • Anstee DJ; Infection Sciences, Southmead Hospital North Bristol NHS Trust, Bristol, UK.
  • Toye AM; Population Health Sciences, University of Bristol, Bristol, UK.
Transfus Med ; 32(3): 261-262, 2022 06.
Article in En | MEDLINE | ID: mdl-35332587
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Von Willebrand Factor / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Von Willebrand Factor / COVID-19 Type of study: Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article